NCT04830228View on ClinicalTrials.gov

BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions

Active, not recruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

August 10, 2021

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2028

Conditions
Peripheral Artery Disease
Interventions
DEVICE

Ballon expandable stent and PTA

Endovascular treatment for the peripheral artery disease of the Iliac artery

Trial Locations (15)

1800

Az Jan Potaels Vilvoorde, Vilvoorde

3600

Zol Genk, Genk

9000

UZ Gent, Ghent

11100

Hôpital Privé du grand Narbonne, Narbonne

24939

Diakonissenkrankenhaus, Flensburg

48145

St. Franziskushospital Münster, Münster

72076

Universitätsklinikum Tübingen, Tübingen

95445

Klinikum Bayreuth, Bayreuth

Unknown

LKH Univ.-Klinikum Graz, Ambulanz für Angiologie, Graz

Regionaal Ziekenhuis Heilig Hart Tienen, Tienen

Hôpital Ambroise Paré, Paris

Universitätsklinikum Essen, Essen

Universitätsklinikum Jena, Jena

Semmelweis University Hospital, Budapest

Pauls Stradins Clinical University Hospital, Riga

Sponsors

Lead Sponsor

Biotronik AG
All Listed Sponsors
lead

Biotronik AG

INDUSTRY